|
|
FDADocs 5/5/2008 | 0 (0) | 21 | 1 | 0 | English
FDA Review of Apheresis SubmissionsJudy Ellen CiaraldiBS, MT(ASCP)SBB, CQA(ASQ)Consumer Safety Officer, DBA, OBRR, CBERAugust 15, 2007OutlineResources for FDA Apheresis Review ... more>>
FDADocs 5/9/2008 | 0 (0) | 78 | 1 | 0 | English
Judy Staffa, co-leads, presiding. PRESENT: SOLOMON IYASU JUDY STAFFA LANA PAULS GERALD DAL PAN FDA FDA ... more>>
FDADocs 5/5/2008 | 0 (0) | 77 | 1 | 0 | English
Case 8:03-cv-01663-RAL-MSSDocument 64Filed 09/14/2004Page 1 of 13UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION UNITED STATES OF AMERICA, Pl... ... more>>
FDADocs 5/8/2008 | 0 (0) | 119 | 1 | 0 | English
Food Reviews International, 2(1), 79-107(1986)IRRADIATION O FOODS- F AN FDA PERSPECTIVE GEORGE H. PAULI and CLYDE A. TAKEGUCHIFood and Dmg Administration Center for Food Safety and Applied ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 45 | 1 | 0 | English
Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLPDocument issued on: June 2004U.S. Department of Health and Human Services Food and Drug ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 68 | 1 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau... ... more>>
FDADocs 5/8/2008 | 0 (0) | 12 | 1 | 0 | English
Cancer Nanotechnology: New Opportunities for Targeted TherapiesFDA Public Meeting October 10, 2006Piotr Grodzinski, Ph.D. Director, Nanotechnology for Cancer Programs Office of Technology and ... more>>
FDADocs 5/9/2008 | 0 (0) | 30 | 1 | 0 | English
FDA Briefing PackageCardiovascular and Renal Drugs Advisory CommitteeNovember 16, 2005Application: NDA 21-628 Certican?? (everolimus) Tablets Indication: Prophylaxis of organ rejection in ... more>>
FDADocs 5/9/2008 | 0 (0) | 67 | 1 | 0 | English
Evaluation of Biotechnology-Derived Pharmaceuticals (July 1997) (http://www.fda.gov/cder/guidance ... more>>
FDADocs 5/9/2008 | 0 (0) | 37 | 1 | 0 | English
DIVISION OF DRUG ONCOLOGY PRODUCTS Briefing Document for Oncology Drug Advisory Committee NDA: Applicant: Established Drug Name: 21-986, N-000 Bristol-Myers Squibb Dasatinib (BMS-3... ... more>>
FDADocs 5/9/2008 | 0 (0) | 23 | 1 | 0 | English
DIVISION OF DRUG ONCOLOGY PRODUCTS Briefing Document for Oncology Drug Advisory Committee NDA: Applicant: Established Drug Name: 21-986, N-000 Bristol-Myers Squibb Dasatinib (BMS-3... ... more>>
FDADocs 5/5/2008 | 0 (0) | 19 | 1 | 0 | English
FDA/PQRI Workshop on A Drug Quality System in the 21st CenturyApril 22-24, 2003 Renaissance Washington DC Hotel Washington, DCTable of ContentsWorkshop Information Goals and Objectives ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 51 | 1 | 0 | English
Industry and FDA StaffDocument Issued on: November 2, 2007This document supersedes the... contact Chester T. Reynolds, 240-276-0157 or mailto:Chester.Reynolds@fda.hhs.govU.S. Department ... more>>
FDADocs 5/9/2008 | 0 (0) | 59 | 1 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
FDADocs 5/5/2008 | 0 (0) | 18 | 1 | 0 | English
Fenwal Automated Devices: FDA Licensing Workshop August 2007Agenda??? ALYX??? ??? ??? ??? Double LR RBCs LR RBCs/Plasma Non-LR Double RBCs (limited launch) Plasma (not in distribution ... more>>
| | | |
| results / page 15/25/50 |
Page: 3 of 33
|
3...
|
|